Inventor · disambiguated record
Mitchell S. Steiner
Also filed as: STEINER MITCHELL S · STEINER Mitchell
37 granted patents·48 pending applications·716 citations·filing 1997–2025
98Inventor score
Top patents by PatentIndex Score
85 records- 0197US6838484B2Formulations comprising selective androgen receptor modulatorsUNIV TENNESSEE RES FOUNDATION·Filed 2002·Granted Jan 4, 2005·137 cites·85 claims
- 0296US7026500B2Halogenated selective androgen receptor modulators and methods of use thereofUNIV TENNESSEE RES FOUNDATION·Filed 2003·Granted Apr 11, 2006·109 cites·24 claims
- 0395US7855229B2Treating wasting disorders with selective androgen receptor modulatorsUNIV TENNESSEE RES FOUNDATION·Filed 2005·Granted Dec 21, 2010·20 cites·12 claims
- 0494US6632447B1Method for chemoprevention of prostate cancerUNIV TENNESSEE RES CORP·Filed 2000·Granted Oct 14, 2003·58 cites·34 claims
- 0592US6899888B2Prevention and treatment of androgen-deprivation induced osteoporosisGTX INC·Filed 2002·Granted May 31, 2005·52 cites·63 claims
- 0692US6410043B1Method for chemoprevention of prostate cancerUNIV TENNESSEE RES CORP·Filed 2000·Granted Jun 25, 2002·37 cites·17 claims
- 0791US8008348B2Treating muscle wasting with selective androgen receptor modulatorsUNIV TENNESSEE RES FOUNDATION·Filed 2004·Granted Aug 30, 2011·31 cites·48 claims
- 0891US6413535B1Method for chemoprevention of prostate cancerUNIV TENNESSEE RES CORP·Filed 2000·Granted Jul 2, 2002·33 cites·20 claims
- 0990US10258596B2Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)GTX INC·Filed 2016·Granted Apr 16, 2019·4 cites·4 claims
- 1090US7547728B2Treating muscle wasting with selective androgen receptor modulatorsUNIV TENNESSEE RES FOUNDATION·Filed 2002·Granted Jun 16, 2009·40 cites·84 claims
- 1188US6413534B1Method for chemoprevention of prostate cancerUNIV TENNESSEE RES CORP·Filed 2000·Granted Jul 2, 2002·21 cites·17 claims
- 1288US6413533B1Method for chemoprevention of prostate cancerUNIV TENNESSEE RES CORP·Filed 2000·Granted Jul 2, 2002·34 cites·34 claims
- 1387US9913815B2Treating androgen deprivation therapy induced hot flashes and bone loss in men using cis-clomipheneASPEN PARK PHARMACEUTICALS INC·Filed 2015·Granted Mar 13, 2018·6 cites·39 claims
- 1487US9744149B2Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)GTX INC·Filed 2015·Granted Aug 29, 2017·3 cites·12 claims
- 1587US7705182B2Multi-substituted selective androgen receptor modulators and methods of use thereofUNIV TENNESSEE RES FOUNDATION·Filed 2003·Granted Apr 27, 2010·28 cites·23 claims
- 1685US9969683B2Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)GTX INC·Filed 2013·Granted May 15, 2018·3 cites·9 claims
- 1785US9624161B2Estrogen receptor ligands and methods of use thereofGTX INC·Filed 2014·Granted Apr 18, 2017·4 cites·15 claims
- 1885US7803970B2Multi-substitued selective androgen receptor modulators and methods of use thereofUNIV TENNESSEE RES FOUNDATION·Filed 2004·Granted Sep 28, 2010·19 cites·74 claims
- 1984US10849873B2Non-invasive method of evaluating breast cancers for selective androgen receptor modulator (SARM) therapyGTX INC·Filed 2019·Granted Dec 1, 2020·1 cites·8 claims
- 2084US9622992B2Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)GTX INC·Filed 2014·Granted Apr 18, 2017·3 cites·29 claims
- 2181US8546451B2Estrogen receptor ligands and methods of use thereofDALTON JAMES T·Filed 2010·Granted Oct 1, 2013·6 cites·24 claims
- 2280US9427418B2Estrogen receptor ligands and methods of use thereofDALTON JAMES T·Filed 2011·Granted Aug 30, 2016·4 cites·14 claims
- 2380US7776921B2Treating benign prostate hyperplasia with SARMSUNIV TENNESSEE RES FOUNDATION·Filed 2003·Granted Aug 17, 2010·11 cites·15 claims
- 2478US10314807B2Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)GTX INC·Filed 2016·Granted Jun 11, 2019·1 cites·5 claims
- 2577US7595402B2Prodrugs of selective androgen receptor modulators and methods of use thereofGTX INC·Filed 2004·Granted Sep 29, 2009·9 cites·11 claims
- 2675US10463635B2Treating androgen deprivation therapy induced hot flashes and bone loss in men using cis-clomipheneASPEN PARK PHARMACEUTICALS INC·Filed 2018·Granted Nov 5, 2019·1 cites·31 claims
- 2775US9051267B2Estrogen receptor ligands and methods of use thereofGTX INC·Filed 2013·Granted Jun 9, 2015·2 cites·10 claims
- 2874US11648236B2Methods of treating coronavirusVERU INC·Filed 2021·Granted May 16, 2023·1 cites·33 claims
- 2974US9604916B2Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)GTX INC·Filed 2013·Granted Mar 28, 2017·2 cites·14 claims
- 3073US7524866B2Prevention and treatment of androgen—deprivation induced osteoporosisGTX INC·Filed 2004·Granted Apr 28, 2009·3 cites·63 claims
- 3170US12115146B2Treatment of skeletal-related events for breast cancer patientsUNIV TENNESSEE RES FOUND·Filed 2020·Granted Oct 15, 2024·0 cites·12 claims
- 3265US12240834B2Polymorphs of [2-(1H-indol-3-yl)-1H-imidazol-4- yl] (3,4,5-trimethoxyphenyl)methanone and its saltsVERU INC·Filed 2023·Granted Mar 4, 2025·0 cites·12 claims
- 3365US6265448B1Method for chemoprevention of prostate cancerUNIV TENNESSEE RES CORP·Filed 1999·Granted Jul 24, 2001·28 cites·19 claims
- 3463US10758500B2Treating androgen deprivation therapy induced hot flashes and bone loss in men using cis-clomipheneASPEN PARK PHARMACEUTICALS INC·Filed 2019·Granted Sep 1, 2020·0 cites·31 claims
- 3563US2004186185A1Method for treatment and chemoprevention of prostate cancerFiled 2003·Application pending·0 cites
- 3663US2004176470A1Method for treatment and chemoprevention of prostate cancerFiled 2003·Application pending·0 cites
- 3763US2006287400A1Method for treatment and chemoprevention of prostate cancerSTEINER MITCHELL S·Filed 2005·Application pending·0 cites
- 3862US2005171073A1Composition and method for treatment and chemoprevention of prostate cancerFiled 2005·Application pending·0 cites
- 3958US2025170091A1Uses of selective androgen receptor modulator (sarm) compounds in chronic weight managementVERU INC·Filed 2024·Application pending·0 cites
- 4057US2006287282A1Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereofSTEINER MITCHELL S·Filed 2004·Application pending·0 cites
- 4156US2006258628A1Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereofSTEINER MITCHELL S·Filed 2004·Application pending·0 cites
- 4256US2007197664A1Prevention and treatment of androgen-deprivation induced osteoporosisSTEINER MITCHELL S·Filed 2007·Application pending·0 cites
- 4355US2021228529A1Pharmaceutical compositions for treating breast cancers and methods of uses thereofUNIV TENNESSEE RES FOUND·Filed 2021·Application pending·0 cites
- 4455US2018214507A1COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTSVERU INC·Filed 2018·Application pending·0 cites
- 4554US2007135407A1Serm reduction of lipid profilesSTEINER MITCHELL S·Filed 2006·Application pending·0 cites
- 4654US2004214898A1Methods for treating hot flashesFiled 2004·Application pending·0 cites
- 4753US2004213841A1Methods for treating hot flashes and gynecomastiaSTEINER MITCHELL S·Filed 2003·Application pending·0 cites
- 4853US2006276539A1Treating Androgen Decline in Aging Male (ADAM)- associated conditions with SARMSDALTON JAMES T·Filed 2006·Application pending·0 cites
- 4953US2023265081A1Methods of treating coronavirusVERU INC·Filed 2023·Application pending·0 cites
- 5052US2004096510A1Prevention and treatment of androgen-deprivation induced osteoporosisFiled 2003·Application pending·0 cites
Showing the top 50 of 85 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mitchell S. Steiner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →